Your search matched 52 results
In a new Harvard Business Review article, brand positioning expert Denise Lee Yohn distills some of the most useful marketing points gleaned from her 25 years of marketing leadership.
Is the market prepared for DTx?
With there being so many different stakeholders, including patients, providers and payers, panelists at the 2019 Digital Medicine & MedTech Showcase pointed to a number of different adoption roadblocks—and successes.
Digital health company Peerwell created an app to prepare patients for surgery and, in turn, reduce the amount of time they spend in the hospital.
Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.
Where will digital therapeutics or DTx be in five years?
The Innovation Authority, the arm of the Israeli government responsible for advancing industrial R&D throughout the country, has given a multi-million-dollar grant to Zebra Medical Vision, a digital health startup.
Deploying ambassadors to speak at the marketing conference DigiPharma Connect, Snapchat is vying to position itself as the best social media outlet for pharma marketing.
Ernest Quintana knew he had long suffered from a deadly lung disease when he was rushed to the hospital, but the news of his imminent death still profoundly shocked him and his family—not because of its grimness but who delivered it: a robot.
Two pharma leaders, Eli Lilly and Johnson & Johnson, have begun disclosing product list prices in their TV commercials, taking the plunge that many brands are still approaching nervously.
As it prepares to go public, Uber, which expects to sell an eye-popping $10 billion of stock during its initial public offering, is simultaneously mapping out its continued expansion into health care.
Last week, many Amazon Prime members received more than their usual flow of order confirmations and shipping notifications, with the retail leviathan inviting some users to “Meet PillPack, a new member of the Amazon family.”
Health care was a central part of the discussion at this year’s Facebook F8.
Based on data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, one of the largest-ever clinical trials for depression, a startup called Taliaz is helping physicians pick the right antidepressant therapy off the bat.
With plans to enroll as many as 150,000 American senior citizens, Johnson & Johnson is collaborating with Apple on HEARTLINE, a revolutionary new study to detect atrial fibrillation (AFib), a potentially lethal condition that can lead to heart palpitations and stroke.
Responding to rampant criticism of rising drug prices, pharma giant Eli Lilly will begin selling an authorized generic of its preeminent insulin therapy, Humalog, at half-price.
At the BrightInsight Ecosystem Event, which explores use cases and best practices in digital health, Harvard Business School Professor Gary Loveman shared some lessons for health care professionals gleaned from his unconventional career path.
A New York Times op-ed highlights the problems in American healthcare that are making doctors depressed.
Forget Market Research. | Blog
It’s no surprise that one encounters many veteran journalists in the marketing world: clear and compelling storytelling is invaluable to a brand.
For decades, an Alzheimers cure has eluded scientists, who can only recognize the disease once it’s too late.
The elimination of CMOs at Johnson & Johnson, Uber and McDonalds highlights how marketing technologies are changing marketing at its core.